Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation

To examine the risk of treatment emergent, cardiovascular serious adverse events associated with varenicline use for tobacco cessation. Meta-analysis comparing study effects using four summary estimates. Medline, Cochrane Library, online clinical trials registries, and reference lists of identified articles. Judith Prochaska, PhD, MPH, is Associate Professor in the Department of Medicine at Stanford University with the Stanford Prevention Research Center.

Publication

 

Image courtesy of interviewee

Leave a Reply

Your email address will not be published.

×
Guest visitors to the Faculti website can view any insight monthly. You have insight(s) remaining for this month

Register for free as an individual and view thousands of insights in our archive today or subscribe for subject access.

You may already have institutional access to Faculti. Please access Faculti using your institution credentials.

Copyright © Faculti Media Limited 2022. All rights reserved.
Recommend Faculti to your librarian

error: